CLP36, also known as cytoplasmic LIM domain protein 36, serves a pivotal role in the orchestration of actin cytoskeleton dynamics and is crucial for maintaining cellular structure and facilitating various cell functions such as migration, adhesion, and proliferation. It functions by acting as a scaffold for the assembly of multiprotein complexes, particularly at sites of actin filament formation, thereby influencing actin organization and cell morphology. CLP36 interacts with several key proteins involved in cytoskeletal rearrangements, including alpha-actinin, which links actin filaments to give structural support to the cell's architecture. Through these interactions, CLP36 supports the formation of stress fibers, focal adhesions, and cell junctions, highlighting its essential role in transmitting mechanical and signaling cues within the cell. This dynamic regulation of the cytoskeleton is critical for cells to adapt to their environment, enabling processes such as wound healing, tissue remodeling, and even metastatic dissemination in pathological states.
The activation of CLP36 is a complex process involving multiple signaling pathways that enhance its ability to interact with the actin cytoskeleton and other associated proteins. Activation typically occurs through post-translational modifications, such as phosphorylation, which can alter its conformation and affinity for binding partners. Additionally, the localization of CLP36 within the cell can be regulated by signaling molecules, directing it to specific sites where actin polymerization and depolymerization occur. This targeted activation is essential for the temporal and spatial regulation of cytoskeletal dynamics, allowing cells to quickly respond to internal and external stimuli. For example, during cell migration, activated CLP36 is directed to the leading edge of the cell, where it facilitates the assembly of actin structures necessary for cell movement. Furthermore, the interaction of CLP36 with proteins such as LIM kinases and testin is integral to its role in stabilizing actin filaments and regulating cell adhesion. These interactions not only support the structural integrity of cells but also mediate the transmission of signals from the extracellular matrix to the nucleus, affecting gene expression and cell behavior. Understanding the mechanisms of CLP36 activation and its role in cytoskeletal dynamics offers profound insights into cellular physiology and the potential to elucidate novel targets for modulating cell function in disease and regeneration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, leading to PKA activation which can phosphorylate targets that modulate CLP36's interaction with the actin cytoskeleton. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which can phosphorylate proteins that associate with CLP36, potentially enhancing its cytoskeletal functions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Raises intracellular calcium, activating pathways that could potentiate CLP36's role in anchoring actin filaments. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits phosphatases, altering phosphorylation states of proteins that may enhance CLP36's activity in actin binding. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits phosphatases PP1 and PP2A, potentially increasing the phosphorylation of proteins involved in CLP36-mediated actin dynamics. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits protein kinases, which could enhance CLP36's scaffolding properties by affecting actin organization. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, potentially enhancing CLP36's interaction with proteins in the Wnt signaling pathway that affect actin structure. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
PKC inhibitor that could enhance CLP36's activity by shifting phosphorylation states favoring actin cytoskeletal organization. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, which can indirectly enhance CLP36's role in actin filament stabilization. | ||||||